Matches in SemOpenAlex for { <https://semopenalex.org/work/W2090983051> ?p ?o ?g. }
- W2090983051 endingPage "829" @default.
- W2090983051 startingPage "824" @default.
- W2090983051 abstract "Study Type – Prognosis (inception cohort) Level of Evidence 1b OBJECTIVE To evaluate the relationship between testosterone levels and the development of high‐risk prostate cancer, by prospectively examining serum androgen concentrations in a well‐studied cohort, as the role of testosterone in prostate cancer progression is debated. PATIENTS AND METHODS The study comprised 781 men in the Baltimore Longitudinal Study of Aging who had sex steroid measurements before a diagnosis of prostate cancer, or at their last visit for those without cancer (no cancer, 636; cancer, not high risk, 109; cancer, high risk, 36). High‐risk cancer was defined as death from prostate cancer, a prostate specific antigen (PSA) level of ≥20 ng/mL at diagnosis, or a Gleason score of ≥8. The hazard ratio (HR) of high‐risk disease was determined using a Cox proportional hazards regression model with simple updating, and risk rates were stratified by age and tercile for androgens of interest based on the proportional hazards analyses. RESULTS The likelihood of high‐risk prostate cancer doubled per unit (0.1) increase in the free testosterone index (FTI) for patients aged >65 years (HR 2.07, 95% confidence interval, CI, 1.01–4.23; P = 0.047); the likelihood for men aged ≤65 years was inversely related to the FTI (HR 0.96, 95% CI 0.35–2.6; P = 0.9). The risk rate per person‐years increased from lowest to highest tercile of FTI for the oldest men (age >70 years) but this trend was not apparent among younger men. CONCLUSION Higher levels of serum free testosterone are associated with an increased risk of aggressive prostate cancer among older men. These data highlight the importance of prospective trials to insure the safety of testosterone‐replacement therapy." @default.
- W2090983051 created "2016-06-24" @default.
- W2090983051 creator A5016188477 @default.
- W2090983051 creator A5022488909 @default.
- W2090983051 creator A5029009031 @default.
- W2090983051 creator A5030777401 @default.
- W2090983051 creator A5039707350 @default.
- W2090983051 creator A5048526962 @default.
- W2090983051 date "2010-02-25" @default.
- W2090983051 modified "2023-10-18" @default.
- W2090983051 title "Serum testosterone is associated with aggressive prostate cancer in older men: results from the Baltimore Longitudinal Study of Aging" @default.
- W2090983051 cites W1570622790 @default.
- W2090983051 cites W1983712096 @default.
- W2090983051 cites W1988261420 @default.
- W2090983051 cites W1992811319 @default.
- W2090983051 cites W2032165027 @default.
- W2090983051 cites W2032800737 @default.
- W2090983051 cites W2045638615 @default.
- W2090983051 cites W2047385722 @default.
- W2090983051 cites W2078454619 @default.
- W2090983051 cites W2079923576 @default.
- W2090983051 cites W2092425553 @default.
- W2090983051 cites W2095618848 @default.
- W2090983051 cites W2098247759 @default.
- W2090983051 cites W2103003357 @default.
- W2090983051 cites W2113645951 @default.
- W2090983051 cites W2116544030 @default.
- W2090983051 cites W2119760980 @default.
- W2090983051 cites W2119776733 @default.
- W2090983051 cites W2120158027 @default.
- W2090983051 cites W2130795076 @default.
- W2090983051 cites W2139893960 @default.
- W2090983051 cites W2143858821 @default.
- W2090983051 cites W2152043963 @default.
- W2090983051 cites W2164735763 @default.
- W2090983051 cites W2276902499 @default.
- W2090983051 cites W2395065221 @default.
- W2090983051 cites W3135529189 @default.
- W2090983051 cites W4362207783 @default.
- W2090983051 doi "https://doi.org/10.1111/j.1464-410x.2009.08853.x" @default.
- W2090983051 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2848292" @default.
- W2090983051 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19751256" @default.
- W2090983051 hasPublicationYear "2010" @default.
- W2090983051 type Work @default.
- W2090983051 sameAs 2090983051 @default.
- W2090983051 citedByCount "80" @default.
- W2090983051 countsByYear W20909830512012 @default.
- W2090983051 countsByYear W20909830512013 @default.
- W2090983051 countsByYear W20909830512014 @default.
- W2090983051 countsByYear W20909830512015 @default.
- W2090983051 countsByYear W20909830512016 @default.
- W2090983051 countsByYear W20909830512017 @default.
- W2090983051 countsByYear W20909830512018 @default.
- W2090983051 countsByYear W20909830512019 @default.
- W2090983051 countsByYear W20909830512020 @default.
- W2090983051 countsByYear W20909830512021 @default.
- W2090983051 countsByYear W20909830512022 @default.
- W2090983051 countsByYear W20909830512023 @default.
- W2090983051 crossrefType "journal-article" @default.
- W2090983051 hasAuthorship W2090983051A5016188477 @default.
- W2090983051 hasAuthorship W2090983051A5022488909 @default.
- W2090983051 hasAuthorship W2090983051A5029009031 @default.
- W2090983051 hasAuthorship W2090983051A5030777401 @default.
- W2090983051 hasAuthorship W2090983051A5039707350 @default.
- W2090983051 hasAuthorship W2090983051A5048526962 @default.
- W2090983051 hasBestOaLocation W20909830511 @default.
- W2090983051 hasConcept C121608353 @default.
- W2090983051 hasConcept C126322002 @default.
- W2090983051 hasConcept C143998085 @default.
- W2090983051 hasConcept C201903717 @default.
- W2090983051 hasConcept C207103383 @default.
- W2090983051 hasConcept C2776235491 @default.
- W2090983051 hasConcept C2779279991 @default.
- W2090983051 hasConcept C2780192828 @default.
- W2090983051 hasConcept C2781406297 @default.
- W2090983051 hasConcept C29456083 @default.
- W2090983051 hasConcept C44249647 @default.
- W2090983051 hasConcept C50382708 @default.
- W2090983051 hasConcept C71924100 @default.
- W2090983051 hasConcept C72563966 @default.
- W2090983051 hasConceptScore W2090983051C121608353 @default.
- W2090983051 hasConceptScore W2090983051C126322002 @default.
- W2090983051 hasConceptScore W2090983051C143998085 @default.
- W2090983051 hasConceptScore W2090983051C201903717 @default.
- W2090983051 hasConceptScore W2090983051C207103383 @default.
- W2090983051 hasConceptScore W2090983051C2776235491 @default.
- W2090983051 hasConceptScore W2090983051C2779279991 @default.
- W2090983051 hasConceptScore W2090983051C2780192828 @default.
- W2090983051 hasConceptScore W2090983051C2781406297 @default.
- W2090983051 hasConceptScore W2090983051C29456083 @default.
- W2090983051 hasConceptScore W2090983051C44249647 @default.
- W2090983051 hasConceptScore W2090983051C50382708 @default.
- W2090983051 hasConceptScore W2090983051C71924100 @default.
- W2090983051 hasConceptScore W2090983051C72563966 @default.
- W2090983051 hasIssue "6" @default.
- W2090983051 hasLocation W20909830511 @default.
- W2090983051 hasLocation W20909830512 @default.
- W2090983051 hasLocation W20909830513 @default.